Insider Selling: HCA Healthcare (NYSE:HCA) COO Sells $5,140,700.00 in Stock

HCA Healthcare, Inc. (NYSE:HCA) COO Jon Foster sold 10,000 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $514.07, for a total value of $5,140,700.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

HCA Healthcare Stock Performance

NYSE:HCA opened at $494.44 on Monday. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The company has a 50 day simple moving average of $443.66 and a two-hundred day simple moving average of $445.25. The company has a market capitalization of $103.28 billion, a PE ratio of 16.38, a P/E/G ratio of 1.65 and a beta of 1.11.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The firm had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. During the same quarter in the previous year, the company earned $6.96 EPS. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. Research analysts predict that HCA Healthcare, Inc. will post 30.15 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is presently 10.34%.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Investors have welcomed expectations that a Democratic-controlled Congress could provide a policy tailwind for hospitals. However, the anticipated relief is not yet enacted and still depends on legislative and funding steps. HCA Healthcare Gains Policy Tailwind
• Positive Sentiment: HCA is expanding AI tools, with its nurse handoff technology heading to 100 hospitals and ambient AI expected to reach 10,000 physicians by year-end. These deployments could support workflow efficiency. AI nurse handoff tool
• Positive Sentiment: Analyst and technical coverage is supportive: Truist reaffirmed its Buy rating, while Zacks highlighted earnings growth, price strength and a bullish moving-average signal. Truist reaffirms Buy rating Zacks stock outlook
• Neutral Sentiment: HCA completed a $6.5 billion senior notes offering. The report confirms the financing but gives limited detail on its use or effect on borrowing costs. Senior notes offering
• Neutral Sentiment: HCA’s AI chief emphasized that delaying a rollout can be appropriate, suggesting a measured approach that may limit near-term adoption while managing implementation risks. HCA AI rollout strategy
• Negative Sentiment: One report flagged potential payer pressure in HCA’s 2027 outlook, a concern for future hospital reimbursement and margins. Payer pressure outlook
• Negative Sentiment: Pomerantz LLP said it is investigating investor claims involving HCA. The announcement provides no findings, but the inquiry may create a legal overhang. Investor investigation announcement

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. BMO Capital Markets assumed coverage on shares of HCA Healthcare in a report on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 price target for the company. Bank of America raised their price objective on HCA Healthcare from $450.00 to $500.00 and gave the company a “neutral” rating in a research note on Wednesday, October 28th. Leerink Partners reaffirmed an “outperform” rating and set a $492.00 target price on shares of HCA Healthcare in a research report on Friday, September 18th. The Goldman Sachs Group decreased their price target on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research note on Tuesday, July 28th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a report on Friday, October 2nd. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $480.13.

Institutional Investors Weigh In On HCA Healthcare

Several institutional investors have recently bought and sold shares of the stock. BlackRock Inc. bought a new stake in shares of HCA Healthcare in the 2nd quarter worth $5,069,974,000. Wellington Management Group LLP raised its holdings in shares of HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after purchasing an additional 799,761 shares during the last quarter. Darsana Capital Partners LP lifted its position in shares of HCA Healthcare by 46.7% during the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after purchasing an additional 350,000 shares in the last quarter. Legal & General Group Plc purchased a new position in HCA Healthcare during the second quarter worth about $410,992,000. Finally, Jupiter Topco LLC bought a new stake in HCA Healthcare in the 2nd quarter worth about $371,138,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine.

The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices.

Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.